The Impact of Macronutrient Composition on Glucose Dynamics in Persons With Type 1 Diabetes
HiLo21
1 other identifier
interventional
12
1 country
1
Brief Summary
A randomized, open-label, three-arm crossover study will be conducted. The aim of the study is to determine the effect of different isocaloric diet macronutrient compositions (High-carbohydrate-Low-fat-Low-protein (HCLFLP), Low-carbohydrate-High-fat-Low-protein (LCHFLP), Low-carbohydrate-Low-fat-High-protein (LCLFHP)) on plasma glucose dynamics in everyday life and during fasted exercise in persons with type 1 diabetes. Our hypothesis is that a HCLFLP diet reduce the decrease in plasma glucose from start to end of fasted exercise compared with a LCHFLP diet. Secondary a LCHFLP compared with a LCLFHP diet does not reduces the decrease in plasma glucose from start to end of fasted exercise. The current study will contribute with new knowledge about the importance of the compositions of a low-carbohydrate diet on glucose dynamics and the influence on plasma glucose during and after cycling in fasted state.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2022
CompletedStudy Start
First participant enrolled
February 3, 2022
CompletedFirst Posted
Study publicly available on registry
March 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2022
CompletedJanuary 9, 2023
January 1, 2023
9 months
January 31, 2022
January 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint is the difference between study arms in difference from start to end plasma glucose concentration during 45 min fasted cycling (assessed by YSI (Yellow Spring Instruments 2900 STAT Plus)).
45 min
Secondary Outcomes (29)
Mean CGM glucose level assessed by CGM during diet interventions
7 days
Time spent < 3.9 mmol/l assessed by CGM during diet interventions
7 days
Time spent < 3.0 mmol/l assessed by CGM during diet interventions
7 days
Time spent 3.9-10.0 mmol/l assessed by CGM during diet interventions
7 days
Time spent > 10.0 mmol/l assessed by CGM during diet interventions
7 days
- +24 more secondary outcomes
Study Arms (3)
High-carbohydrate-low-fat-low-protein diet
ACTIVE COMPARATORLow-carbohydrate-high-fat-low-protein diet
ACTIVE COMPARATORLow-carbohydrate-low-fat-high-protein diet
ACTIVE COMPARATORInterventions
The participants must follow a 7-day high-carbohydrate-low-fat-low-protein diet before the inclinic study visit at day 8. The in-clinic study visits are identical for all the three study arms.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Type 1 diabetes ≥ 5 years
- Insulin pump use ≥ 1 year
- Use of intermittently scanned continuous glucose monitoring (isCGM) or continuous glucose monitoring (CGM) ≥ 3 months
- HbA1c ≤ 69 mmol/mol (8.5%)
- Self-reported hypoglycemia awareness
- Exercising at least 30 minutes at moderate or vigorous intensity two times per week.
You may not qualify if:
- Use of anti-diabetic medicine (other than insulin), corticosteroids or other drugs affecting glucose metabolism during the study period or within 30 days prior to study start
- Use of a hybrid closed-loop system
- Females who are pregnant, breast-feeding or intend to become pregnant during the study period
- Ischemic heart disease
- Severe asthma
- Other concomitant medical or psychological condition that according to the investigator's assessment makes the individual unsuitable for study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Steno Diabetes Center Copenhagenlead
- Swansea Universitycollaborator
Study Sites (1)
Steno Diabetes Center Copenhagen
Herlev, 2730, Denmark
Related Publications (1)
McCarthy OM, Kristensen KB, Christensen MB, Schmidt S, Ranjan AG, Nicholas C, Bain SC, Norgaard K, Bracken R. Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy. Diabetes Obes Metab. 2023 Mar;25(3):878-888. doi: 10.1111/dom.14938. Epub 2023 Jan 3.
PMID: 36482870DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten Nørgaard, Professor
Steno Diabetes Center Copenhagen, Clinical Reseach, Diabetes Technology Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2022
First Posted
March 7, 2022
Study Start
February 3, 2022
Primary Completion
November 8, 2022
Study Completion
November 8, 2022
Last Updated
January 9, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share